COVID-19 Impact on Global Voriconazole, Market Insights and Forecast to 2026

COVID-19 Impact on Global Voriconazole, Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Voriconazole Product Introduction
1.2 Market Segments
1.3 Key Voriconazole Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Voriconazole Market Size Growth Rate by Type
1.4.2 Injection
1.4.3 Freeze-dried Powder
1.5 Market by Application
1.5.1 Global Voriconazole Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Voriconazole Industry Impact
1.6.1 How the Covid-19 is Affecting the Voriconazole Industry
1.6.1.1 Voriconazole Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Voriconazole Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Voriconazole Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Voriconazole Market Size Estimates and Forecasts
2.1.1 Global Voriconazole Revenue 2015-2026
2.1.2 Global Voriconazole Sales 2015-2026
2.2 Voriconazole Market Size by Region: 2020 Versus 2026
2.2.1 Global Voriconazole Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Voriconazole Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Voriconazole Competitor Landscape by Players
3.1 Voriconazole Sales by Manufacturers
3.1.1 Voriconazole Sales by Manufacturers (2015-2020)
3.1.2 Voriconazole Sales Market Share by Manufacturers (2015-2020)
3.2 Voriconazole Revenue by Manufacturers
3.2.1 Voriconazole Revenue by Manufacturers (2015-2020)
3.2.2 Voriconazole Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Voriconazole Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Voriconazole Revenue in 2019
3.2.5 Global Voriconazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Voriconazole Price by Manufacturers
3.4 Voriconazole Manufacturing Base Distribution, Product Types
3.4.1 Voriconazole Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Voriconazole Product Type
3.4.3 Date of International Manufacturers Enter into Voriconazole Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Voriconazole Market Size by Type (2015-2020)
4.1.1 Global Voriconazole Sales by Type (2015-2020)
4.1.2 Global Voriconazole Revenue by Type (2015-2020)
4.1.3 Voriconazole Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Voriconazole Market Size Forecast by Type (2021-2026)
4.2.1 Global Voriconazole Sales Forecast by Type (2021-2026)
4.2.2 Global Voriconazole Revenue Forecast by Type (2021-2026)
4.2.3 Voriconazole Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Voriconazole Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Voriconazole Market Size by Application (2015-2020)
5.1.1 Global Voriconazole Sales by Application (2015-2020)
5.1.2 Global Voriconazole Revenue by Application (2015-2020)
5.1.3 Voriconazole Price by Application (2015-2020)
5.2 Voriconazole Market Size Forecast by Application (2021-2026)
5.2.1 Global Voriconazole Sales Forecast by Application (2021-2026)
5.2.2 Global Voriconazole Revenue Forecast by Application (2021-2026)
5.2.3 Global Voriconazole Price Forecast by Application (2021-2026)
6 North America
6.1 North America Voriconazole by Country
6.1.1 North America Voriconazole Sales by Country
6.1.2 North America Voriconazole Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Voriconazole Market Facts & Figures by Type
6.3 North America Voriconazole Market Facts & Figures by Application
7 Europe
7.1 Europe Voriconazole by Country
7.1.1 Europe Voriconazole Sales by Country
7.1.2 Europe Voriconazole Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Voriconazole Market Facts & Figures by Type
7.3 Europe Voriconazole Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Voriconazole by Region
8.1.1 Asia Pacific Voriconazole Sales by Region
8.1.2 Asia Pacific Voriconazole Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Voriconazole Market Facts & Figures by Type
8.3 Asia Pacific Voriconazole Market Facts & Figures by Application
9 Latin America
9.1 Latin America Voriconazole by Country
9.1.1 Latin America Voriconazole Sales by Country
9.1.2 Latin America Voriconazole Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Voriconazole Market Facts & Figures by Type
9.3 Central & South America Voriconazole Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Voriconazole by Country
10.1.1 Middle East and Africa Voriconazole Sales by Country
10.1.2 Middle East and Africa Voriconazole Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Voriconazole Market Facts & Figures by Type
10.3 Middle East and Africa Voriconazole Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description, Business Overview and Total Revenue
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Voriconazole Products Offered
11.1.5 Pfizer Recent Development
11.2 Teva
11.2.1 Teva Corporation Information
11.2.2 Teva Description, Business Overview and Total Revenue
11.2.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Teva Voriconazole Products Offered
11.2.5 Teva Recent Development
11.3 GeneTech Pharm
11.3.1 GeneTech Pharm Corporation Information
11.3.2 GeneTech Pharm Description, Business Overview and Total Revenue
11.3.3 GeneTech Pharm Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GeneTech Pharm Voriconazole Products Offered
11.3.5 GeneTech Pharm Recent Development
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Description, Business Overview and Total Revenue
11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novartis Voriconazole Products Offered
11.4.5 Novartis Recent Development
11.5 Mylan
11.5.1 Mylan Corporation Information
11.5.2 Mylan Description, Business Overview and Total Revenue
11.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mylan Voriconazole Products Offered
11.5.5 Mylan Recent Development
11.6 Squibb
11.6.1 Squibb Corporation Information
11.6.2 Squibb Description, Business Overview and Total Revenue
11.6.3 Squibb Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Squibb Voriconazole Products Offered
11.6.5 Squibb Recent Development
11.7 Sandoz
11.7.1 Sandoz Corporation Information
11.7.2 Sandoz Description, Business Overview and Total Revenue
11.7.3 Sandoz Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sandoz Voriconazole Products Offered
11.7.5 Sandoz Recent Development
11.8 Daiichi Sankyo
11.8.1 Daiichi Sankyo Corporation Information
11.8.2 Daiichi Sankyo Description, Business Overview and Total Revenue
11.8.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Daiichi Sankyo Voriconazole Products Offered
11.8.5 Daiichi Sankyo Recent Development
11.9 GSK
11.9.1 GSK Corporation Information
11.9.2 GSK Description, Business Overview and Total Revenue
11.9.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.9.4 GSK Voriconazole Products Offered
11.9.5 GSK Recent Development
11.10 Cilag AG
11.10.1 Cilag AG Corporation Information
11.10.2 Cilag AG Description, Business Overview and Total Revenue
11.10.3 Cilag AG Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Cilag AG Voriconazole Products Offered
11.10.5 Cilag AG Recent Development
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description, Business Overview and Total Revenue
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Voriconazole Products Offered
11.1.5 Pfizer Recent Development
11.12 Abbott
11.12.1 Abbott Corporation Information
11.12.2 Abbott Description, Business Overview and Total Revenue
11.12.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Abbott Products Offered
11.12.5 Abbott Recent Development
11.13 Takeda
11.13.1 Takeda Corporation Information
11.13.2 Takeda Description, Business Overview and Total Revenue
11.13.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Takeda Products Offered
11.13.5 Takeda Recent Development
11.14 Sichuan Beauty Sport Huakang Pharmaceutical
11.14.1 Sichuan Beauty Sport Huakang Pharmaceutical Corporation Information
11.14.2 Sichuan Beauty Sport Huakang Pharmaceutical Description, Business Overview and Total Revenue
11.14.3 Sichuan Beauty Sport Huakang Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Sichuan Beauty Sport Huakang Pharmaceutical Products Offered
11.14.5 Sichuan Beauty Sport Huakang Pharmaceutical Recent Development
11.15 Jincheng HEALTH Pharmaceutical
11.15.1 Jincheng HEALTH Pharmaceutical Corporation Information
11.15.2 Jincheng HEALTH Pharmaceutical Description, Business Overview and Total Revenue
11.15.3 Jincheng HEALTH Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Jincheng HEALTH Pharmaceutical Products Offered
11.15.5 Jincheng HEALTH Pharmaceutical Recent Development
11.16 Ebang Pharmaceutical
11.16.1 Ebang Pharmaceutical Corporation Information
11.16.2 Ebang Pharmaceutical Description, Business Overview and Total Revenue
11.16.3 Ebang Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Ebang Pharmaceutical Products Offered
11.16.5 Ebang Pharmaceutical Recent Development
11.17 Aditya Pharma
11.17.1 Aditya Pharma Corporation Information
11.17.2 Aditya Pharma Description, Business Overview and Total Revenue
11.17.3 Aditya Pharma Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Aditya Pharma Products Offered
11.17.5 Aditya Pharma Recent Development
11.18 Taj Pharmaceuticals
11.18.1 Taj Pharmaceuticals Corporation Information
11.18.2 Taj Pharmaceuticals Description, Business Overview and Total Revenue
11.18.3 Taj Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Taj Pharmaceuticals Products Offered
11.18.5 Taj Pharmaceuticals Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Voriconazole Market Estimates and Projections by Region
12.1.1 Global Voriconazole Sales Forecast by Regions 2021-2026
12.1.2 Global Voriconazole Revenue Forecast by Regions 2021-2026
12.2 North America Voriconazole Market Size Forecast (2021-2026)
12.2.1 North America: Voriconazole Sales Forecast (2021-2026)
12.2.2 North America: Voriconazole Revenue Forecast (2021-2026)
12.2.3 North America: Voriconazole Market Size Forecast by Country (2021-2026)
12.3 Europe Voriconazole Market Size Forecast (2021-2026)
12.3.1 Europe: Voriconazole Sales Forecast (2021-2026)
12.3.2 Europe: Voriconazole Revenue Forecast (2021-2026)
12.3.3 Europe: Voriconazole Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Voriconazole Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Voriconazole Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Voriconazole Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Voriconazole Market Size Forecast by Region (2021-2026)
12.5 Latin America Voriconazole Market Size Forecast (2021-2026)
12.5.1 Latin America: Voriconazole Sales Forecast (2021-2026)
12.5.2 Latin America: Voriconazole Revenue Forecast (2021-2026)
12.5.3 Latin America: Voriconazole Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Voriconazole Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Voriconazole Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Voriconazole Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Voriconazole Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Voriconazole Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Voriconazole Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Voriconazole Market Segments
Table 2. Ranking of Global Top Voriconazole Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Voriconazole Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Injection
Table 5. Major Manufacturers of Freeze-dried Powder
Table 6. COVID-19 Impact Global Market: (Four Voriconazole Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Voriconazole Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Voriconazole Players to Combat Covid-19 Impact
Table 11. Global Voriconazole Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Voriconazole Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Voriconazole Sales by Regions 2015-2020 (K MT)
Table 14. Global Voriconazole Sales Market Share by Regions (2015-2020)
Table 15. Global Voriconazole Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Voriconazole Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Voriconazole Sales Share by Manufacturers (2015-2020)
Table 18. Global Voriconazole Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Voriconazole by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Voriconazole as of 2019)
Table 20. Voriconazole Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Voriconazole Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Voriconazole Price (2015-2020) (USD/MT)
Table 23. Voriconazole Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Voriconazole Product Type
Table 25. Date of International Manufacturers Enter into Voriconazole Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Voriconazole Sales by Type (2015-2020) (K MT)
Table 28. Global Voriconazole Sales Share by Type (2015-2020)
Table 29. Global Voriconazole Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Voriconazole Revenue Share by Type (2015-2020)
Table 31. Voriconazole Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Voriconazole Sales by Application (2015-2020) (K MT)
Table 33. Global Voriconazole Sales Share by Application (2015-2020)
Table 34. North America Voriconazole Sales by Country (2015-2020) (K MT)
Table 35. North America Voriconazole Sales Market Share by Country (2015-2020)
Table 36. North America Voriconazole Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Voriconazole Revenue Market Share by Country (2015-2020)
Table 38. North America Voriconazole Sales by Type (2015-2020) (K MT)
Table 39. North America Voriconazole Sales Market Share by Type (2015-2020)
Table 40. North America Voriconazole Sales by Application (2015-2020) (K MT)
Table 41. North America Voriconazole Sales Market Share by Application (2015-2020)
Table 42. Europe Voriconazole Sales by Country (2015-2020) (K MT)
Table 43. Europe Voriconazole Sales Market Share by Country (2015-2020)
Table 44. Europe Voriconazole Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Voriconazole Revenue Market Share by Country (2015-2020)
Table 46. Europe Voriconazole Sales by Type (2015-2020) (K MT)
Table 47. Europe Voriconazole Sales Market Share by Type (2015-2020)
Table 48. Europe Voriconazole Sales by Application (2015-2020) (K MT)
Table 49. Europe Voriconazole Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Voriconazole Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Voriconazole Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Voriconazole Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Voriconazole Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Voriconazole Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Voriconazole Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Voriconazole Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Voriconazole Sales Market Share by Application (2015-2020)
Table 58. Latin America Voriconazole Sales by Country (2015-2020) (K MT)
Table 59. Latin America Voriconazole Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Voriconazole Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Voriconazole Revenue Market Share by Country (2015-2020)
Table 62. Latin America Voriconazole Sales by Type (2015-2020) (K MT)
Table 63. Latin America Voriconazole Sales Market Share by Type (2015-2020)
Table 64. Latin America Voriconazole Sales by Application (2015-2020) (K MT)
Table 65. Latin America Voriconazole Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Voriconazole Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Voriconazole Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Voriconazole Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Voriconazole Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Voriconazole Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Voriconazole Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Voriconazole Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Voriconazole Sales Market Share by Application (2015-2020)
Table 74. Pfizer Corporation Information
Table 75. Pfizer Description and Major Businesses
Table 76. Pfizer Voriconazole Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Pfizer Product
Table 78. Pfizer Recent Development
Table 79. Teva Corporation Information
Table 80. Teva Description and Major Businesses
Table 81. Teva Voriconazole Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Teva Product
Table 83. Teva Recent Development
Table 84. GeneTech Pharm Corporation Information
Table 85. GeneTech Pharm Description and Major Businesses
Table 86. GeneTech Pharm Voriconazole Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. GeneTech Pharm Product
Table 88. GeneTech Pharm Recent Development
Table 89. Novartis Corporation Information
Table 90. Novartis Description and Major Businesses
Table 91. Novartis Voriconazole Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Novartis Product
Table 93. Novartis Recent Development
Table 94. Mylan Corporation Information
Table 95. Mylan Description and Major Businesses
Table 96. Mylan Voriconazole Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Mylan Product
Table 98. Mylan Recent Development
Table 99. Squibb Corporation Information
Table 100. Squibb Description and Major Businesses
Table 101. Squibb Voriconazole Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Squibb Product
Table 103. Squibb Recent Development
Table 104. Sandoz Corporation Information
Table 105. Sandoz Description and Major Businesses
Table 106. Sandoz Voriconazole Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Sandoz Product
Table 108. Sandoz Recent Development
Table 109. Daiichi Sankyo Corporation Information
Table 110. Daiichi Sankyo Description and Major Businesses
Table 111. Daiichi Sankyo Voriconazole Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Daiichi Sankyo Product
Table 113. Daiichi Sankyo Recent Development
Table 114. GSK Corporation Information
Table 115. GSK Description and Major Businesses
Table 116. GSK Voriconazole Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. GSK Product
Table 118. GSK Recent Development
Table 119. Cilag AG Corporation Information
Table 120. Cilag AG Description and Major Businesses
Table 121. Cilag AG Voriconazole Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Cilag AG Product
Table 123. Cilag AG Recent Development
Table 124. Macherey-Nagel GmbH Corporation Information
Table 125. Macherey-Nagel GmbH Description and Major Businesses
Table 126. Macherey-Nagel GmbH Voriconazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. Macherey-Nagel GmbH Product
Table 128. Macherey-Nagel GmbH Recent Development
Table 129. Abbott Corporation Information
Table 130. Abbott Description and Major Businesses
Table 131. Abbott Voriconazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. Abbott Product
Table 133. Abbott Recent Development
Table 134. Takeda Corporation Information
Table 135. Takeda Description and Major Businesses
Table 136. Takeda Voriconazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 137. Takeda Product
Table 138. Takeda Recent Development
Table 139. Sichuan Beauty Sport Huakang Pharmaceutical Corporation Information
Table 140. Sichuan Beauty Sport Huakang Pharmaceutical Description and Major Businesses
Table 141. Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 142. Sichuan Beauty Sport Huakang Pharmaceutical Product
Table 143. Sichuan Beauty Sport Huakang Pharmaceutical Recent Development
Table 144. Jincheng HEALTH Pharmaceutical Corporation Information
Table 145. Jincheng HEALTH Pharmaceutical Description and Major Businesses
Table 146. Jincheng HEALTH Pharmaceutical Voriconazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 147. Jincheng HEALTH Pharmaceutical Product
Table 148. Jincheng HEALTH Pharmaceutical Recent Development
Table 149. Ebang Pharmaceutical Corporation Information
Table 150. Ebang Pharmaceutical Description and Major Businesses
Table 151. Ebang Pharmaceutical Voriconazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 152. Ebang Pharmaceutical Product
Table 153. Ebang Pharmaceutical Recent Development
Table 154. Aditya Pharma Corporation Information
Table 155. Aditya Pharma Description and Major Businesses
Table 156. Aditya Pharma Voriconazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 157. Aditya Pharma Product
Table 158. Aditya Pharma Recent Development
Table 159. Taj Pharmaceuticals Corporation Information
Table 160. Taj Pharmaceuticals Description and Major Businesses
Table 161. Taj Pharmaceuticals Voriconazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 162. Taj Pharmaceuticals Product
Table 163. Taj Pharmaceuticals Recent Development
Table 164. Global Voriconazole Sales Forecast by Regions (2021-2026) (K MT)
Table 165. Global Voriconazole Sales Market Share Forecast by Regions (2021-2026)
Table 166. Global Voriconazole Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 167. Global Voriconazole Revenue Market Share Forecast by Regions (2021-2026)
Table 168. North America: Voriconazole Sales Forecast by Country (2021-2026) (K MT)
Table 169. North America: Voriconazole Revenue Forecast by Country (2021-2026) (US$ Million)
Table 170. Europe: Voriconazole Sales Forecast by Country (2021-2026) (K MT)
Table 171. Europe: Voriconazole Revenue Forecast by Country (2021-2026) (US$ Million)
Table 172. Asia Pacific: Voriconazole Sales Forecast by Region (2021-2026) (K MT)
Table 173. Asia Pacific: Voriconazole Revenue Forecast by Region (2021-2026) (US$ Million)
Table 174. Latin America: Voriconazole Sales Forecast by Country (2021-2026) (K MT)
Table 175. Latin America: Voriconazole Revenue Forecast by Country (2021-2026) (US$ Million)
Table 176. Middle East and Africa: Voriconazole Sales Forecast by Country (2021-2026) (K MT)
Table 177. Middle East and Africa: Voriconazole Revenue Forecast by Country (2021-2026) (US$ Million)
Table 178. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 179. Key Challenges
Table 180. Market Risks
Table 181. Main Points Interviewed from Key Voriconazole Players
Table 182. Voriconazole Customers List
Table 183. Voriconazole Distributors List
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Voriconazole Product Picture
Figure 2. Global Voriconazole Sales Market Share by Type in 2020 & 2026
Figure 3. Injection Product Picture
Figure 4. Freeze-dried Powder Product Picture
Figure 5. Global Voriconazole Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Voriconazole Report Years Considered
Figure 10. Global Voriconazole Market Size 2015-2026 (US$ Million)
Figure 11. Global Voriconazole Sales 2015-2026 (K MT)
Figure 12. Global Voriconazole Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Voriconazole Sales Market Share by Region (2015-2020)
Figure 14. Global Voriconazole Sales Market Share by Region in 2019
Figure 15. Global Voriconazole Revenue Market Share by Region (2015-2020)
Figure 16. Global Voriconazole Revenue Market Share by Region in 2019
Figure 17. Global Voriconazole Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Voriconazole Revenue in 2019
Figure 19. Voriconazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Voriconazole Sales Market Share by Type (2015-2020)
Figure 21. Global Voriconazole Sales Market Share by Type in 2019
Figure 22. Global Voriconazole Revenue Market Share by Type (2015-2020)
Figure 23. Global Voriconazole Revenue Market Share by Type in 2019
Figure 24. Global Voriconazole Market Share by Price Range (2015-2020)
Figure 25. Global Voriconazole Sales Market Share by Application (2015-2020)
Figure 26. Global Voriconazole Sales Market Share by Application in 2019
Figure 27. Global Voriconazole Revenue Market Share by Application (2015-2020)
Figure 28. Global Voriconazole Revenue Market Share by Application in 2019
Figure 29. North America Voriconazole Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Voriconazole Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Voriconazole Sales Market Share by Country in 2019
Figure 32. North America Voriconazole Revenue Market Share by Country in 2019
Figure 33. U.S. Voriconazole Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Voriconazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Voriconazole Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Voriconazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Voriconazole Market Share by Type in 2019
Figure 38. North America Voriconazole Market Share by Application in 2019
Figure 39. Europe Voriconazole Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Voriconazole Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Voriconazole Sales Market Share by Country in 2019
Figure 42. Europe Voriconazole Revenue Market Share by Country in 2019
Figure 43. Germany Voriconazole Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Voriconazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Voriconazole Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Voriconazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Voriconazole Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Voriconazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Voriconazole Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Voriconazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Voriconazole Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Voriconazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Voriconazole Market Share by Type in 2019
Figure 54. Europe Voriconazole Market Share by Application in 2019
Figure 55. Asia Pacific Voriconazole Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Voriconazole Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Voriconazole Sales Market Share by Region in 2019
Figure 58. Asia Pacific Voriconazole Revenue Market Share by Region in 2019
Figure 59. China Voriconazole Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Voriconazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Voriconazole Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Voriconazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Voriconazole Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Voriconazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Voriconazole Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Voriconazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Voriconazole Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Voriconazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Voriconazole Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Voriconazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Voriconazole Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Voriconazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Voriconazole Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Voriconazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Voriconazole Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Voriconazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Voriconazole Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Voriconazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Voriconazole Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Voriconazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Voriconazole Market Share by Type in 2019
Figure 82. Asia Pacific Voriconazole Market Share by Application in 2019
Figure 83. Latin America Voriconazole Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Voriconazole Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Voriconazole Sales Market Share by Country in 2019
Figure 86. Latin America Voriconazole Revenue Market Share by Country in 2019
Figure 87. Mexico Voriconazole Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Voriconazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Voriconazole Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Voriconazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Voriconazole Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Voriconazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Voriconazole Market Share by Type in 2019
Figure 94. Latin America Voriconazole Market Share by Application in 2019
Figure 95. Middle East and Africa Voriconazole Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Voriconazole Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Voriconazole Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Voriconazole Re

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Cephalosporin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 109

Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections. Cephalosporin originally derived from The fungus Acremonium, which was previously known as "Cephalosporium". The global Cephalosporin market was valued at US$ 1380.7 million in 2023 and is anticipated to reach US$ 1346.9 million by 2030, witnessing a CAGR of -0.3% during The forecast period 2024-2030. Market competition is intense. Qilu Antibiotics, Nectar Lifes......

Global Polymixin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120

According to our LPI (LP Information) latest study, the global Polymixin market size was valued at US$ 229.9 million in 2023. With growing demand in downstream market, the Polymixin is forecast to a readjusted size of US$ 291 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Polymixin market. Polymixin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......

Global Sepsis Partnering Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 78

The Sepsis Partnering market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sepsis Partnering market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape......

Global Cephalosporin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 156

According to our LPI (LP Information) latest study, the global Cephalosporin market size was valued at US$ 1350.7 million in 2023. With growing demand in downstream market, the Cephalosporin is forecast to a readjusted size of US$ 1319.6 million by 2030 with a CAGR of -0.3% during review period. The research report highlights the growth potential of the global Cephalosporin market. Cephalosporin are expected to show stable growth in the future market. However, product differentiation, re......

Global Amoxicillin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127

According to our LPI (LP Information) latest study, the global Amoxicillin market size was valued at US$ 4512.7 million in 2023. With growing demand in downstream market, the Amoxicillin is forecast to a readjusted size of US$ 5711.7 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Amoxicillin market. Amoxicillin are expected to show stable growth in the future market. However, product differentiation, reducing co......

Global Metronidazole Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136

According to our LPI (LP Information) latest study, the global Metronidazole market size was valued at US$ 110.5 million in 2023. With growing demand in downstream market, the Metronidazole is forecast to a readjusted size of US$ 106.6 million by 2030 with a CAGR of -0.5% during review period. The research report highlights the growth potential of the global Metronidazole market. Metronidazole are expected to show stable growth in the future market. However, product differentiation, redu......

Global Drugs for Herpes Labialis (Oral Herpes) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Drugs for Herpes Labialis (Oral Herpes) market size was valued at US$ 2404.5 million in 2023. With growing demand in downstream market, the Drugs for Herpes Labialis (Oral Herpes) is forecast to a readjusted size of US$ 3402.2 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Drugs for Herpes Labialis (Oral Herpes) market. Drugs for Herpes Labialis (Ora......

Global Ampicillin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Ampicillin market size was valued at US$ 161.6 million in 2023. With growing demand in downstream market, the Ampicillin is forecast to a readjusted size of US$ 194.7 million by 2030 with a CAGR of 2.7% during review period. The research report highlights the growth potential of the global Ampicillin market. Ampicillin are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......

Global Acinetobacter Infections Treatment Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101

According to our LPI (LP Information) latest study, the global Acinetobacter Infections Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Acinetobacter Infections Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Acinetobacter Infections Treatment market. Acinetobacter Infections Treatment are expected to show stable ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs